Vaxil Provides Update of Conversion of Previously Issued Convertible Debt and the Granting of Options
September 17, 2020 08:30 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Sept. 17, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Positive Results on CorVax™ in vivo Study
September 08, 2020 08:40 ET
|
Vaxil Bio Ltd.
NOT FOR DISTRIBUTION BY US NEWSWIRE OR IN UNITED STATES NESS-ZIONA, Israel, Sept. 08, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Update on In Vivo Study
August 27, 2020 10:51 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, Aug. 27, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Cancels Brokered Private Placement
July 31, 2020 16:30 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, July 31, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Provides Pre-Clinical and Business Update
July 20, 2020 08:52 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, July 20, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Private Placement Extension
June 29, 2020 16:05 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, June 29, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative...
Vaxil Announces Brokered Private Placement
May 26, 2020 07:55 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, May 26, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Collaboration Agreement With The Tel Aviv Sourasky Medical Center (Ichilov Hospital), Israel’s Leading Tertiary Care Facility
May 05, 2020 09:00 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, May 05, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
Vaxil Announces Audited Annual Results and Provides Business Update
April 28, 2020 09:10 ET
|
Vaxil Bio Ltd.
NESS-ZIONA, Israel, April 28, 2020 (GLOBE NEWSWIRE) -- VAXIL BIO LTD. (“Vaxil” or the “Company”) (TSX VENTURE: VXL), an innovative immunotherapy biotech company specializing in cancer and infectious...
CORRECTION: VAXIL PROVIDES UPDATE ON PRECLINICAL EXPERIMENT
April 13, 2020 13:58 ET
|
Vaxil Bio Ltd.
Not for distribution by US newswire or in United States NESS-ZIONA, Israel, April 13, 2020 (GLOBE NEWSWIRE) -- A correction has been issued for the release disseminated at 8:30 AM, April 13th....